Diagnostics Market Research Reports & Industry Analysis
The global diagnostics industry plays a critical role in disease prevention, detection, and treatment across a wide range of medical fields—and it’s also a big business with significant opportunities for growth and innovation. As the industry continues to change, staying up to date on the latest trends and insights is essential.
New Diagnostics Industry Reports Produced by Industry Experts
To help organizations understand the market on a deeper level and better navigate the shifting business landscape, MarketResearch.com offers a wide range of diagnostics market research reports. These studies cover both the in vitro diagnostics and medical imaging segments, providing information on market sizing, growth forecasts, market share, mergers and acquisitions, new product development, competitive analysis, and corporate profiling. With coverage of disruptive trends and emerging technologies, our reports give you the knowledge you need to stay ahead of market changes.
What Are the Benefits of Using MarketResearch.com?
- At MarketResearch.com, we understand the value of timely and reliable research. With over 20 years of experience in the field of market research, we have become a leading source of insights and analysis.
- We bring together reports from hundreds of leading firms, making it easy to find the information you need in one place.
- Our knowledgeable research specialists have worked closely with many top diagnostics industry companies and can offer personalized assistance to help you find reports that fit your research requirements.
- With our comprehensive coverage and expert analysis, you will be better positioned to gain a competitive edge in the global diagnostics industry.
Diagnostics Industry Research & Market Reports
-
Cell Surface Markers
... at a CAGR of 9.4% over the analysis period 2024-2030. Antibodies, one of the segments analyzed in the report, is expected to record a 11.0% CAGR and reach US$981.1 Million by the end of the ... Read More
-
Radiation Detection, Monitoring and Safety Products
... reach US$3.0 Billion by 2030, growing at a CAGR of 4.1% over the analysis period 2024-2030. Detection & Monitoring, one of the segments analyzed in the report, is expected to record a 4.6% CAGR and ... Read More
-
Radioactive Materials Logistics
... at a CAGR of 4.1% over the analysis period 2024-2030. Fresh Fuel Radioactive Materials, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$3.0 Billion by the ... Read More
-
Hereditary Testing
... CAGR of 6.2% over the analysis period 2024-2030. Preimplantation Genetic Diagnosis & Screening, one of the segments analyzed in the report, is expected to record a 7.1% CAGR and reach US$4.6 Billion by the end ... Read More
-
Image-Guided Therapy Systems
... at a CAGR of 5.6% over the analysis period 2024-2030. Endoscopes, one of the segments analyzed in the report, is expected to record a 6.5% CAGR and reach US$1.7 Billion by the end of the ... Read More
-
Medical Digital Imaging Systems
... 2030, growing at a CAGR of 7.4% over the analysis period 2024-2030. X-Ray, one of the segments analyzed in the report, is expected to record a 7.3% CAGR and reach US$12.9 Billion by the end ... Read More
-
Molecular Quality Controls
... at a CAGR of 5.0% over the analysis period 2024-2030. Independent Controls, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$211.3 Million by the end of ... Read More
-
Over The Counter (OTC) Testing
... Billion by 2030, growing at a CAGR of 9.4% over the analysis period 2024-2030. Glucose Monitoring Tests, one of the segments analyzed in the report, is expected to record a 8.2% CAGR and reach US$11.7 ... Read More
-
Particle Therapy
... CAGR of 8.8% over the analysis period 2024-2030. Proton Therapy, one of the segments analyzed in the report, is expected to record a 9.2% CAGR and reach US$2.3 Billion by the end of the analysis ... Read More
-
Procedure Trays
... CAGR of 11.2% over the analysis period 2024-2030. Operating Rooms, one of the segments analyzed in the report, is expected to record a 11.9% CAGR and reach US$31.2 Billion by the end of the analysis ... Read More
-
X-ray Inspection Systems
... at a CAGR of 6.0% over the analysis period 2024-2030. Digital Imaging, one of the segments analyzed in the report, is expected to record a 6.2% CAGR and reach US$925.2 Million by the end of ... Read More
-
Preimplantation Genetic Testing
... at a CAGR of 10.1% over the analysis period 2024-2030. Reagents & Consumables, one of the segments analyzed in the report, is expected to record a 10.8% CAGR and reach US$794.1 Million by the end ... Read More
-
Prostate Cancer Diagnostics
... at a CAGR of 13.3% over the analysis period 2024-2030. Preliminary, one of the segments analyzed in the report, is expected to record a 12.6% CAGR and reach US$10.0 Billion by the end of the ... Read More
-
Automated and Rapid Microbiological Tests
... Billion by 2030, growing at a CAGR of 6.7% over the analysis period 2024-2030. GC/CRT (Clinical), one of the segments analyzed in the report, is expected to record a 8.0% CAGR and reach US$1.3 Billion ... Read More
-
Brachytherapy
... 4.3% over the analysis period 2024-2030. High Dose Rate, one of the segments analyzed in the report, is expected to record a 3.7% CAGR and reach US$1.6 Billion by the end of the analysis period. ... Read More
-
Biosensors
... 7.2% over the analysis period 2024-2030. Non-wearable, one of the segments analyzed in the report, is expected to record a 6.6% CAGR and reach US$28.3 Billion by the end of the analysis period. Growth in ... Read More
-
Cholesterol Testing
... CAGR of 4.4% over the analysis period 2024-2030. Diagnostic Centers, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$11.6 Billion by the end of the analysis ... Read More
-
Blood Gas and Electrolyte Analyzers
... Billion by 2030, growing at a CAGR of 5.3% over the analysis period 2024-2030. Portable, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$823.6 Million by ... Read More
-
Immunoassay Systems
... CAGR of 3.6% over the analysis period 2024-2030. Reagents & Kits, one of the segments analyzed in the report, is expected to record a 3.5% CAGR and reach US$19.4 Billion by the end of the ... Read More
-
Hemoglobin A1C (HbA1C) Testing
... 2030, growing at a CAGR of 8.1% over the analysis period 2024-2030. Ion-Exchange High Performance Liquid Chromatography (HPLC), one of the segments analyzed in the report, is expected to record a 8.6% CAGR and reach ... Read More
-
Molecular Diagnostics
... CAGR of 9.2% over the analysis period 2024-2030. Reagents & Kits, one of the segments analyzed in the report, is expected to record a 9.7% CAGR and reach US$16.0 Billion by the end of the ... Read More
-
Radiopharmaceuticals
... 11.0% over the analysis period 2024-2030. Oncology, one of the segments analyzed in the report, is expected to record a 12.6% CAGR and reach US$6.9 Billion by the end of the analysis period. Growth in ... Read More
-
Plastic Films
... CAGR of 5.8% over the analysis period 2024-2030. LLDPE, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$93.5 Billion by the end of the analysis period. ... Read More
-
Clinical Chemistry Analyzers
... at a CAGR of 4.9% over the analysis period 2024-2030. Reagents, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$12.5 Billion by the end of the ... Read More
-
Nucleic Acid Testing
... at a CAGR of 4.5% over the analysis period 2024-2030. Nucleic Acid Test Kits, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$3.7 Billion by the ... Read More